| R&D Center |
|
|
 |
| Contact Us |
 |
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China |
 |
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621 |
 |
Fax: +86-531-88817925 |
 |
Zip Code: 250101 |
 |
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com |
|
|
|
| Medicine project |
Now Position:Home > R&D Center > Medicine project < Anti-Cancer Drugs |
|
| Item Number |
Product Name |
Registry Classification |
Indication |
Progress |
| 004 |
palbociclib |
H 3+3 |
N.A |
N.A |
| 008 |
Bortezomib |
H 3+6 |
N.A |
N.A |
| 011 |
To be Named |
H 1+1 |
N.A |
Molecular structure determined, in pharmaceutical research |
| 012 |
HAP-SN-38 |
H 1+1 |
N.A |
Synthesis process finished, in pharmaceutical research |
| 013 |
To be Named |
H 1+1 |
N.A |
Molecular structure determined, in pharmaceutical research |
|
|
|
